The State of Diagnostics Today
Providers rely on centralized lab facilities to run many common diagnostics. Provider overhead is high, costs are high, workflow is inefficient, care is delayed.
Our Solution
Our patented technology provides high-sensitivity, quantified results in a fraction of the time, for a fraction of the cost. It supercharges existing ubiquitous Lateral Flow Assays (LFAs) to increase sensitivity by 10x while providing quantified results.
Competitive Landscape
We compete with higher-priced, time-consuming central lab diagnostic machines on the high-end, and less-sensitive LFA readers on the low-end.
Our Growth Strategy
We identify strategic areas to apply our technology and then license and support key players in those areas for commercialization. We will continue as an R&D company to develop and license technology in the broader point-of-care market.